Endogenous aryl hydrocarbon receptor (AhR) agonist (Ki
= 3 nM). Decreases Oct4 levels in U87 glioblastoma cells. Induces stem-like cancer cell differentiation in U87 tumor spheres and inhibits ovarian cancer cell proliferation in vitro
. Suppresses tumor growth in U87 and OVCAR-3 cell xenografts in mice. Also inhibits TGF-β
-induced human myofibroblast differentiation.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Sold under license, US Patent Application 2002183524
A ligand for the aryl hydrocarbon receptor isolated from lung.
Song et al.
The aryl hydrocarbon receptor ligand ITE inhibits TGF�1-induced human myofibroblast differentiation.
Lehmann et al.
Tryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cells.
Cheng et al.
An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells.
Wang et al.
Cancer Lett., 2013;340:63
The citations listed below are publications that use Tocris products. Selected citations for ITE include:
Showing Results 1 - 4 of 4